Skip to main content
Log in

Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Rectal treatment with enemas, foams, and suppositories is the most efficient method of delivering an adequate quantity of locally active drugs to the distal colon. In a pilot study carried out by colonoscopy in four patients, it was observed that 4 g 5-ASA in 20 ml foam spread up or beyond the splenic flexure and more extensively than 2 g 5-ASA in 10 ml foam. Therefore we have undertaken a study in order to compare by scintigraphy the colonic distribution of 4 g 5-ASA foam versus 4 g 5-ASA in 100 ml liquid enemas in 10 patients with ulcerative colitis using a crossover randomized design. Both preparations were labeled with 100 MBq [99mTc] sulfur colloid before administration. Anterior scans were taken at intervals for 4 hr. Activity, expressed as a percentage of total radioactivity, was measured in the rectum, sigmoid, descending, transverse, and ascending colon. Six patients had the same extent of spread with the two formulations; in three patients with foam and in one patient with enema a greater spread was observed. the foam reached the upper limit of disease in all cases, while enema failed in two cases. The maximum spread with foam was observed within 30 min in nine of 10 patients compared with seven of 10 after enema. Compared to enema, foam distributes more uniformly and seems to persist longer in the descending and sigmoid colon. The 5-ASA colonic foam shows some more favorable characteristics than enema for the local treatment of left-sided ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lee DAH, Taylor M, James VHT, Walker G: Rectally administered prednisolone-evidence for a predominantly local action. Gut 21:215–218, 1980

    Google Scholar 

  2. Azad Khan AK, Piris J, Truelove SC: An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 2:892–895, 1977

    Google Scholar 

  3. Truelove SC: Treatment of ulcerative colitis with local hydrocortisone. Br Med J 2:1267–1272, 1956

    Google Scholar 

  4. Matts SG: Local treatment of ulcerative colitis with prednisolone-21-phosphate retention enemata. Lancet 1:517–519, 1960

    Google Scholar 

  5. Spencer JS, Kirsner JB: Experience with short and long term courses of local adrenal steroid therapy for ulcerative colitis: Report of 98 cases. Gastroenterology 42:669, 1962

    Google Scholar 

  6. Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, Franzin G, Battocchia A, Labò G, Dal Monte PR: Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. 2: 270–271, 1981

  7. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuck E, Borgen L: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894–1898, 1987

    Google Scholar 

  8. Farmer RG, Schumaker OP: Treatment of ulcerative colitis with hydrocortisone enemas: Relationship of hydrocortisone absorption, adrenal suppression, and clinical response. Dis Colon Rectum 13:355–361, 1970

    Google Scholar 

  9. Lee DAH, Taylor GM, James VHT, Walker G: Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut 20:349–355, 1979

    Google Scholar 

  10. Campieri M, Lanfranchi GA, Boschi S, Brignola C, Bazzocchi G, Gionchetti P, Minguzzi MR, Belluzzi A, Labò G: Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut 26:400–405, 1985

    Google Scholar 

  11. Hanauer SB: 5-ASA enema therapy. Neth J Med 35:S11-S20, 1989

    Google Scholar 

  12. Ruddell WS, Dickinson RJ, Dixon MF, Axon AT: Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: Comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 21:885–889, 1980

    Google Scholar 

  13. Sommerville KW, Langman MJ, Kane SP, MacGilchrist AJ, Watkinson G, Salmon P: Effect of treatment on symptoms and quality of life in patients ulcerative colitis: Comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. Br Med J 291:886, 1985

    Google Scholar 

  14. Farthing MJG, Rutland MD, Clark ML: Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. Br Med J 2:822–824, 1979

    Google Scholar 

  15. Hay DJ, Sharma H, Irving MH: Spread of steroid-containing foam after intrarectal administration. Br Med J 1:1751–1753, 1979

    Google Scholar 

  16. Wood E, Wilson CG, Hardy JG: The spreading of foam and solution enemas. Int J Pharmacol 25:191–197, 1985

    Google Scholar 

  17. Campieri M, Lanfranchi GA, Brignola C, Bazzocchi G, Gionchetti P, Minguzzi MR, Cappello IP, Corbelli C, Boschi S: Retrograde spread of 5-aminosalicylic enemas in patients with active colitis. Dis Colon Rectum 29:108–110, 1986

    Google Scholar 

  18. Williams CN, Haber G, Aquino GA: Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal colitis and measurement of extend of spread using99mTc-labeled 5-ASA suppositories. Dig Dis Sci 32:71S-75S, 1987

    Google Scholar 

  19. Kruis W, Bull U, Eisenburg J, Paumgartner G: Retrograde colonic spread of sulfasalazine enemas. Scand J Gastroenterol 17:933–938, 1982

    Google Scholar 

  20. Van Buul MMC, Mulder CJJ, Wiltink EHH, Van Royen EA, Tytgat GNJ: Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease. Hepato-Gastroenterol 36:199–201, 1989

    Google Scholar 

  21. Hardy JG, Lee SW, Clark AG, Reynolds JR: Enema volume and spreading. Int J Pharmacol 31:151–155, 1986

    Google Scholar 

  22. Jay M, Digenis GA, Foster TS, Antonow DR: Retrograde spreading of hydrocortisone enema in inflammatory bowel disease. Dig Dis Sci 31:139–144, 1986

    Google Scholar 

  23. Vitti RA, Meyers F, Knight LC, Siegel JA, Malmud LS, Fisher RS: Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis. Dis Colon Rectum 29:108–110, 1986

    Google Scholar 

  24. Hardy JG, Wood E, Clark AG, Reynolds JR: Colonic motility and enema spreading. Eur J Nucl Med 12:176–178, 1986

    Google Scholar 

  25. Campieri M, Bianchi P, Porro G, Brunetti G, D'Albasio G, Capurso L, Cottone M, De Franchis R, Miglioli M, Pallone F, Paoluzi P, Pera A, Prantera C, Sturniolo GC: Therapeutic evaluation of mesalazine foam (Asacol) versus mesalazine enema in the treatment of distal ulcerative colitis. Gastroenterology 100:A200, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by Bracco S.p.A (Milan, Italy).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Campieri, M., Corbelli, C., Gionchetti, P. et al. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Digest Dis Sci 37, 1890–1897 (1992). https://doi.org/10.1007/BF01308084

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308084

Key Words

Navigation